Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Beta
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
David A. Scheinberg, MD, PhD
/
Co-authored with Aaron Chang
Co-authored publications
David A. Scheinberg, MD, PhD and Aaron Chang · 11 publications
CSV
Word
Engineering CAR-T cells to activate small-molecule drugs in situ.
Nature chemical biology
· 2021
DA
David A. Scheinberg
AY
Aaron Y Chang
CM
Christopher M Bourne
KK
Keifer Kurtz
BC
Broderick C Corless
+2 more →
PMID:
34969970
·
PMCID:
PMC9152922
·
DOI
·
77 citations
·
Abstract
Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform.
Cancer immunology research
· 2020
DA
David A. Scheinberg
AY
Aaron Y Chang
RS
Ron S Gejman
HF
Heather F Jones
CY
Claire Y Oh
+1 more →
PMID:
32184297
·
PMCID:
PMC7310334
·
DOI
·
35 citations
·
Abstract
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
Cancer discovery
· 2020
DA
David A. Scheinberg
AY
Aaron Y Chang
MT
Matt Teater
LF
Lorena Fontan
HY
Hsia-Yuan Ying
+3 more →
PMID:
31915197
·
PMCID:
PMC7275250
·
DOI
·
146 citations
·
Abstract
ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.
Cancer immunology research
· 2019
DA
David A. Scheinberg
AY
Aaron Y Chang
CY
Claire Y Oh
CB
Christopher Bourne
MM
Megan M Dacek
+1 more →
PMID:
31540894
·
PMCID:
PMC6891198
·
DOI
·
40 citations
·
Abstract
Rejection of immunogenic tumor clones is limited by clonal fraction.
eLife
· 2018
DA
David A. Scheinberg
AY
Aaron Y Chang
RS
Ron S Gejman
HF
Heather F Jones
KD
Krysta DiKun
+1 more →
PMID:
30499773
·
PMCID:
PMC6269121
·
DOI
·
107 citations
·
Abstract
CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes.
Leukemia
· 2017
DA
David A. Scheinberg
AY
A Y Chang
MD
M D Mathias
PMID:
28745331
·
PMCID:
PMC5628131
·
DOI
·
12 citations
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
The Journal of clinical investigation
· 2017
DA
David A. Scheinberg
AY
Aaron Y Chang
RS
Ron S Gejman
LD
Leonid Dubrovsky
MD
Melissa D Mathias
PMID:
28628042
·
PMCID:
PMC5490756
·
DOI
·
79 citations
·
Abstract
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations.
JCI insight
· 2017
DA
David A. Scheinberg
AY
Aaron Y Chang
EJ
Elliott J Brea
HW
Hans-Guido Wendel
PMID:
28352655
·
PMCID:
PMC5358483
·
DOI
·
40 citations
·
Abstract
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells.
Cancer immunology research
· 2016
DA
David A. Scheinberg
AY
Aaron Y Chang
EJ
Elliott J Brea
CY
Claire Y Oh
SB
Sadna Budhu
+6 more →
PMID:
27680026
·
PMCID:
PMC5110210
·
DOI
·
154 citations
·
Abstract
Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Expert opinion on biological therapy
· 2016
DA
David A. Scheinberg
AY
Aaron Y Chang
RS
Ron S Gejman
EJ
Elliott J Brea
CY
Claire Y Oh
+1 more →
PMID:
27094818
·
PMCID:
PMC4936943
·
DOI
·
56 citations
·
Abstract
T cell receptor mimic antibodies for cancer therapy.
Oncoimmunology
· 2015
DA
David A. Scheinberg
AY
Aaron Y Chang
LD
Leonid Dubrovsky
RS
Ron S Gejman
EJ
Elliott J Brea
+1 more →
PMID:
26942058
·
PMCID:
PMC4760335
·
DOI
·
41 citations
·
Abstract